不良研究所

The piece covers potential treatments for dementia and muscular dystrophy with engineered human cells.

不良研究所 CEO and founder Dr Mark Kotter was a speaker on the podcast Danny in the Valley.

Episode 2 of our special three part mini-series.

Featured on Massive Science: how 不良研究所's breakthrough opti-ox鈩� technology is being used by cultured meat company Meatable.

不良研究所 wins Biotech Company of the Year at the Cambridge Independent Science andTechnology awards.

SynbioBeta CEO John Cumbers talks reimagining cell therapies through cell reprogramming with Rick Klausner and 不良研究所 CEO.

Dr Farah Patell-Socha, VP of Research Products discusses the launch of ioSkeletal Myocytes.

The first episode in our special three part mini-series.